Advances in drug development for targeted therapies for glioblastoma
Author:
Affiliation:
1. Department of Neurosurgery, School of Pharmaceutical Sciences, Zhongnan HospitalWuhan UniversityWuhan Hubei China
2. Department of Neurosurgery, Taihe HospitalHubei University of MedicineShiyan Hubei China
Funder
National Health Commission of the People's Republic of China
National Natural Science Foundation of China
Publisher
Wiley
Subject
Drug Discovery,Pharmacology,Molecular Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/med.21676
Reference141 articles.
1. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
2. 2016 World Health Organization classification of central nervous system tumors;Wen PY;Continuum (Minneap Minn),2017
3. The Definition of Primary and Secondary Glioblastoma
4. Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
5. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current strategic arsenal and advances in nose to brain nanotheranostics for therapeutic intervention of glioblastoma multiforme;Journal of Biomaterials Science, Polymer Edition;2024-09-09
2. Enhanced therapeutic efficacy for glioblastoma immunotherapy with an oncolytic herpes simplex virus armed with anti-PD-1 antibody and IL-12;Molecular Therapy: Oncology;2024-06
3. Histone demethylase KDM4B accelerates the progression of glioblastoma via the epigenetic regulation of MYC stability;Clinical Epigenetics;2023-12-13
4. Immunoregulatory liposomes hitchhiking on neutrophils for enhanced carbon ion radiotherapy-assisted immunotherapy of glioblastoma;Nano Today;2023-12
5. Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for Glioblastoma;2023-06-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3